Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.
about
Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complicationsClostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003Bench-to-bedside review: Clostridium difficile colitisThe role of Clostridium difficile in the paediatric and neonatal gut - a narrative reviewClostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal EffectsRecent Advances in the Diagnosis and Treatment of Clostridium Difficile InfectionGastrointestinal dysbiosis and the use of fecal microbial transplantation in Clostridium difficile infectionUltrasensitive Detection and Quantification of Toxins for Optimized Diagnosis of Clostridium difficile InfectionWSES guidelines for management of Clostridium difficile infection in surgical patientsClostridium difficile infection: molecular pathogenesis and novel therapeuticsClostridium difficile Infection in Children: Current State and Unanswered QuestionsAsymptomatic Clostridium difficile colonization: epidemiology and clinical implicationsFecal transplantation for recurrent Clostridium difficile infection in older adults: a reviewNeutralization of Clostridium difficile toxin A with single-domain antibodies targeting the cell receptor binding domainRecurrent Clostridium difficile diarrhoeaTrends in Clostridium difficile Disease: Epidemiology and InterventionAssessment of Clostridium difficile-associated disease surveillance definitions, North Carolina, 2005.The challenges posed by reemerging Clostridium difficile infection.Clostridium difficile infection in inflammatory bowel disease: challenges in diagnosis and treatment.Clostridium difficile Infection and Fecal Microbiota Transplant.[Clostridium difficile infections in geriatric patients].Older Is Not Wiser, Immunologically Speaking: Effect of Aging on Host Response to Clostridium difficile Infections.Clostridium difficile infection: New insights into therapeutic options.Immune responses to Clostridium difficile infectionVancomycin treatment's association with delayed intestinal tissue injury, clostridial overgrowth, and recurrence of Clostridium difficile infection in mice.Adenosine deaminase inhibition prevents Clostridium difficile toxin A-induced enteritis in mice.Identification of risk factors for the development of clostridium difficile-associated diarrhea following treatment of polymicrobial surgical infectionsA prospective study of risk factors and historical trends in metronidazole failure for Clostridium difficile infection.Effect of novel A2A adenosine receptor agonist ATL 313 on Clostridium difficile toxin A-induced murine ileal enteritisIsolation of C. difficile Carriers Alone and as Part of a Bundle Approach for the Prevention of Clostridium difficile Infection (CDI): A Mathematical Model Based on Clinical Study Data.Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole.Hospital-acquired Clostridium difficile-associated disease in the intensive care unit setting: epidemiology, clinical course and outcomeAerial dissemination of Clostridium difficile spores.Equine hyperimmune serum protects mice against Clostridium difficile spore challengeAdenovirus-based vaccination against Clostridium difficile toxin A allows for rapid humoral immunity and complete protection from toxin A lethal challenge in mice.Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube.Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec.Safety and immunogenicity of increasing doses of a Clostridium difficile toxoid vaccine administered to healthy adults.Characterisation and carriage ratio of Clostridium difficile strains isolated from a community-dwelling elderly population in the United Kingdom.The potential value of Clostridium difficile vaccine: an economic computer simulation model.
P2860
Q24542134-F8FD9636-2203-48E4-9572-0AB42B93BB7BQ24627863-34ECCF6F-4D4C-4FA8-BEE3-4E49D65DE61EQ24644191-F93EDBC6-A934-49BD-A7CB-C218F55BB6BDQ26750848-016ED0A9-F1C4-4C16-AF18-0698E732255AQ26751477-0E01D1C8-DBA4-4CF9-AE94-43BBA0C78395Q26766112-6F1BA7CA-9D4D-4456-BD64-2EAAE8275CC7Q26776155-1209602F-0DD3-455E-8770-3828ECDEA807Q26776411-4C59D11C-E966-456D-8B1F-473DA9E61DE8Q26795429-69A33F58-F330-4910-B3E7-DCAE66AB451DQ26864237-1631443E-572E-4DEB-9BF2-B9031645C4FCQ27016320-3A7A3E6D-C576-4B31-AD98-8E70067A0023Q28083860-0427CD6B-F112-4A10-8242-974011CD0DE7Q28294828-209DD5AD-17F4-4553-A7CF-D2854692FAB8Q28302768-F03BAB29-8F8F-40F4-9A89-38E2B60421EFQ28367072-D1984F06-2D10-4E48-A264-D9729980980DQ28655729-4A6717A5-1B55-4054-8C5C-10F4A10D4E44Q30229124-ADCFB6B5-3F0E-4847-9AB1-7901C8ED18E5Q30229530-E783AC97-C320-47BA-A101-AFFB3DCA7378Q30235905-2F10E2D7-EB58-43D2-A40E-764E05C60CA5Q30240065-8C994FE8-B229-4DE1-94F8-78A35DA44070Q30244040-B5F0BC52-72C2-4B81-A715-8737CB5B706AQ30251941-BDBAA41D-1868-4450-BB19-A5676B3007C3Q30252154-563683A9-2D5B-4BDF-8686-19B8DF832A86Q30416692-6A5D0C72-7724-4797-8E19-A75B643EDE93Q30417830-F76CE89F-8E64-4290-B69D-9C8A8F72C899Q30431245-9423D855-5051-4195-BFBA-9D00734342FFQ30433267-69ECDE4E-AA02-45AD-B1DC-7DF9C2E3E6D9Q30437722-11917C26-9610-42CA-A82F-816DA1B3C0A5Q30446178-F3BF7C1B-9DEB-4E75-AAF3-DB1B6DAC347BQ31105341-853EA90F-0B80-48D1-81C9-EB990558EC0EQ33214954-342E63B9-B387-4231-879A-ACDE35D11D11Q33285304-BFC648A1-C031-4047-A3BA-786F699B8070Q33316379-0D5A141C-F94F-4B6A-8AA4-D2D8A26C7D1CQ33865434-BE936DDB-99CD-405C-8080-3E423292C7C8Q33896435-DE0E6511-BEC9-4BC2-8137-E6833A592468Q33964412-9FBE093B-8DE0-4B79-925D-ED1BBB4BCBF0Q33990521-E871F1D5-4D83-4FF0-B4E1-C11411007980Q34006013-D186E65D-D686-423E-8B86-7B18D1346762Q34008750-7E66F7D9-60D1-421C-8DB8-EC309AE64F2FQ34012314-EEF1465A-3B7C-4213-86F8-DCCA585B980C
P2860
Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Asymptomatic carriage of Clost ...... IgG antibody against toxin A.
@ast
Asymptomatic carriage of Clost ...... IgG antibody against toxin A.
@en
type
label
Asymptomatic carriage of Clost ...... IgG antibody against toxin A.
@ast
Asymptomatic carriage of Clost ...... IgG antibody against toxin A.
@en
prefLabel
Asymptomatic carriage of Clost ...... IgG antibody against toxin A.
@ast
Asymptomatic carriage of Clost ...... IgG antibody against toxin A.
@en
P2093
P1476
Asymptomatic carriage of Clost ...... IgG antibody against toxin A.
@en
P2093
P304
P356
10.1056/NEJM200002103420604
P407
P577
2000-02-01T00:00:00Z